CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-κB signaling pathway

Hao Qu(Dalian Medical University), Kun Zou(Dalian Medical University)
Frontiers in Pharmacology
January 13, 2025
Cited by 1


Related Papers